Quantcast
Channel: News Medical vivitrol News Feed
Viewing all articles
Browse latest Browse all 30

Positive topline results from Alkermes ALKS 9070 phase 1b study for schizophrenia

$
0
0
Alkermes, Inc. today announced positive topline results from a phase 1b, double-blind, randomized, placebo-controlled study of ALKS 9070 in patients with schizophrenia.

Viewing all articles
Browse latest Browse all 30

Latest Images

Trending Articles





Latest Images

<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>
<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596344.js" async> </script>